Home › Funds › TRIGLAV INVESTMENTS, D.O.O. › CVS
TRIGLAV INVESTMENTS, D.O.O. position in CVS
CVS Health Corporation · Consumer Staples
TRIGLAV INVESTMENTS, D.O.O. reported holding 112,950 shares of CVS (CVS Health Corporation) in its Q3 2026 13F filing — a position valued at US$9.7M, representing 0.51% of its reported portfolio and ranking #33 among its reported holdings. TRIGLAV INVESTMENTS, D.O.O. has disclosed CVS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR
How TRIGLAV INVESTMENTS, D.O.O.'s CVS position evolved
TRIGLAV INVESTMENTS, D.O.O. first disclosed a stake in CVS in Q4 2024 at 176,080 shares (US$7.9M). The position peaked in Q2 2026 at 112,950 shares, worth US$11.7M. Across 8 filings, TRIGLAV INVESTMENTS, D.O.O. increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 112,950 shares valued at US$9.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 176.08K | $7.90M | New |
| Q1 2025 | 161.56K | $10.95M | Reduce |
| Q2 2025 | 149.15K | $10.29M | Reduce |
| Q3 2025 | 149.15K | $11.24M | Hold |
| Q4 2025 | 115.95K | $9.20M | Reduce |
| Q1 2026 | 112.95K | $8.11M | Reduce |
| Q2 2026 | 112.95K | $11.68M | Hold |
| Q3 2026 | 112.95K | $9.68M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVS and 13F data
CVS (CVS Health Corporation) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- DODGE & COX 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 33.80M sh · $3.50B · Q2 2026
- DAVIS SELECTED ADVISERS 11.87M sh · $1.23B · Q2 2026
- Pzena Investment Management 11.77M sh · $1.22B · Q2 2026
- Clearbridge Investments, LLC 8.54M sh · $883.12M · Q2 2026
- GQG Partners LLC 7.96M sh · $822.99M · Q2 2026
More on TRIGLAV INVESTMENTS, D.O.O.
FAQ
How long has TRIGLAV INVESTMENTS, D.O.O. held CVS?
TRIGLAV INVESTMENTS, D.O.O. has disclosed CVS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is TRIGLAV INVESTMENTS, D.O.O.'s current position in CVS?
As of Q3 2026, TRIGLAV INVESTMENTS, D.O.O. holds 112.95K shares of CVS (CVS Health Corporation), valued at $9.68M, representing 0.51% of its reported portfolio and ranking #33.
Has TRIGLAV INVESTMENTS, D.O.O. been buying or selling CVS?
In the latest 13F filing (Q3 2026), TRIGLAV INVESTMENTS, D.O.O. held unchanged its position in CVS. The position peaked in Q2 2026 at 112.95K shares.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.